CME Response To ICE/NYX

What would I do if I were $CME and saw $ICE buy $NYX? There are three responses.

First is do nothing. Costs you nothing, and allows the firm to pursue its existing strategy. While doing nothing, CME might counsel regulators as to why this is a bad tie up. Delaying the purchase through close examination of the regulations and competitive issues surrounding it might be a good strategy. CME was delayed twice by regulators when it purchased CBOT and NYMEX. Delay eats operating capital.

Second, bid. It’s a market and CME Chairman Terry Duffy knows a lot more than any executive sitting at the table about operating in a market. Construct an appealing hostile bid for $NYX. Similar to what ICE did with CBOT. Unfortunately, regulators probably wouldn’t approve a CME/NYX tie up. The NYC banks would be against it. But, shareholders are capitalists and if CME forced ICE to pay more, they’d appreciate the push. There are all kinds of permutations that one could think of when it came to CME buying and selling off pieces of the NYX. To be honest, for HFT traders, a tie up between those two exchanges would be best.

Third, look to buy something. The two most probably candidates are $NDAQ or $CBOE. However, then they invite the scrutiny of the SEC and the SEC is living in the past. The acquisition of either of those two exchanges doesn’t feel accretive to shareholders-especially owning a stock exchange. CBOE is a possible target, but only because they have a decent product line with decent margins. There is some cross pollination effects between CBOE and CME Group‘s options markets. But, it’s not a slam dunk.

I think if I were CME, my first move would be to offer NYX a combination of cash and stock valued at over $9B. Maybe $9.5B. Make ICE ante up and call.

Related articles

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

Jeffrey Carter is an angel investor and independent trader. He specializes in turning concepts into profits. He co-founded Hyde Park Angels one of the most active angel groups in the United States in April of 2007. He previously served on the Chicago Mercantile Exchange Board of Directors. He has done market commentary for (More...)

This material is provided for informational purposes only, as of the date hereof, and is subject to change without notice.This material may not be suitable for all investors and is not intended to be an offer, or the solicitation of any offer, to buy or sell any securities.